Strong cash flows, robust pipeline positive for Godrej Properties

The pre-sales volume of Godrej Properties (GPL) for third quarter of the financial year 2025 (Q3FY25) declined 6 per cent year-on-year (Y-o-Y) — down 21 per cent quarter-on-quarter (Q-o-Q) — to 4.1 million square feet (msf), resulting in a pre-sales

Is it time to buy or sell Delhivery shares?

Delhivery share price dropped 6.6 per cent to a low of Rs 295.8 per share after analysts cut their earnings estimate on the stock, following weak results for the December quarter (Q3) of the current financial year (FY25). Q3 is

Private sector banks’ credit costs up in Q3FY25 on higher provisions

Private sector banks that announced their earnings for the October-December quarter (Q3) of 2024-25 (FY25) reported a rise in credit costs due to higher provisions, mainly for unsecured retail loans. Axis Bank, Kotak Mahindra Bank, and RBL Bank, which announced

Dr Reddy’s faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy’s Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company’s Q3 performance and differed on its growth outlook. Chairman of Dr. Reddy’s Laboratories,

Power utilities likely to see moderate growth in Q3 earnings

Power utilities may report moderate growth in earnings for Q3FY25. Generation is up 3 per cent year-on-year (Y-o-Y) in Q3 on lower cooling demand and high base, to 429 billion units (BU). Photograph: PTI Photo from the Rediff Archives Peak

Steady heartbeat of growth in diagnostics stock keeps sector pulsing

The stocks of diagnostic service providers have been standout performers within the healthcare sector over the past year, posting returns between 16 and 80 per cent. In comparison, the Nifty 50 saw returns of 8 per cent. Image used for